Joanna Wiensch
Stock Analyst at Citigroup
(1.93)
# 1320
Out of 5,234 analysts
30
Total ratings
68.42%
Success rate
20.12%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Becton Dickinson | Upgrades: Buy | 255 275 | 230.68 | 19.21% | 5 | Oct 1, 2024 | |
Abbott Laboratories | Maintains: Strong Buy | 119 127 | 112.86 | 12.53% | 8 | Aug 22, 2024 | |
Nevro | Downgrades: Neutral | 40 | 3.81 | 949.87% | 1 | Jan 17, 2023 | |
DexCom | Maintains: Buy | 83 91 | 79.7 | 13.24% | 2 | Apr 29, 2020 | |
Cooper Companies | Maintains: Neutral | 90 80 | 92.99 | -14.51% | 2 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 92.17 | 30.19% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 200 | 236.5 | -15.43% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 40 | 155.18 | -74.22% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 168 | 103.56 | 62.22% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 63 | 83.82 | -24.84% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 235 | 361.38 | -34.97% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 220 | 268.11 | -17.94% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 68 | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 84 | 73.55 | 14.21% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 94 | 29.63 | 217.25% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 163 | 143.4 | 13.67% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 124 | 79.75 | 55.49% | 1 | Mar 5, 2020 |